Name: Utilizing Social Media for Professional Development
Start: 2025-03-30T18:30:00-05:00
End: 2025-03-30T20:30:00-05:00
Location: The Chicago Firehouse Restaurant

Utilizing Social Media for Professional Development

Join Women As One for an exclusive networking and panel discussion on how social media can elevate your professional growth.
About this Event

Harness the Power of Social Media for Your Career!

Join Women As One for an exclusive networking and panel discussion on how social media can elevate your professional growth. This engaging event will bring together influential women in cardiology to share insights on personal branding, digital strategy, and online professionalism.

👩‍⚕️ What to Expect:
✅ Learn from top cardiologists who have mastered social media for career success
✅ Gain expert insights on personal branding and digital professionalism
✅ Connect with Women As One and BridgeBio colleagues to expand your network

🎤 Featured Speakers:
✨ Moderator: Gurleen Kaur, MD
✨ Panelists: Payal Kohli, MD, Purvi Parwani, MD, MPH, Poonam Velagapudi, MD
✨ Welcome from: Women As One & Andrea Zider, PhD (VP of Medical Affairs, BridgeBio)

📅 March 30, 6:30 - 8:30 PM CDT
📍 The Chicago Firehouse Restaurant - Kimball and Palmer Room

Don’t miss this chance to build connections, strengthen your digital presence, and gain practical social media strategies from industry leaders!

🎟️ Space is limited! Secure your spot today!

Agenda

6:30 - 6:45pm: Arrival and networking

6:45 - 6:55pm: Welcome and Overview from WAO and BridgeBio

6:55 - 7:40pm: Panel Discussion

7:40 - 8:30pm: Networking

Do you have any questions?

Please contact Heather Mastrogiovanni at [email protected].

About the organizers

Women As One

Women As One is a non-profit organization that provides talented women cardiologists with unique professional opportunities. By supporting women cardiologists in their careers, we can shift the future of healthcare and transform women’s health. Find out more

About BridgeBio

BridgeBio Pharma, Inc. (BridgeBio) is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. More information.